Capula Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$541K Buy
1,100
+200
+22% +$109K ﹤0.01% 501
2025
Q4
$522K Buy
900
+200
+29% +$113K ﹤0.01% 377
2025
Q3
$340K Buy
700
+200
+40% +$93.1K ﹤0.01% 505
2025
Q2
$203K Hold
500
﹤0.01% 373
2025
Q1
$249K Buy
+500
New +$271K ﹤0.01% 459
2024
Q4
Sell
-400
Closed -$247K 598
2024
Q3
$247K Sell
400
-400
-50% -$237K ﹤0.01% 344
2024
Q2
$442K Buy
+800
New +$458K ﹤0.01% 256
2023
Q4
Sell
-1,400
Closed -$709K 566
2023
Q3
$709K Buy
+1,400
New +$746K 0.01% 284
2023
Q2
Sell
-52,900
Closed -$30.5M 773
2023
Q1
$30.5M Buy
52,900
+33,400
+171% +$18.8M 0.37% 56
2022
Q4
$10.7M Sell
19,500
-9,400
-33% -$4.98M 0.14% 174
2022
Q3
$14.7M Buy
+28,900
New +$16.2M 0.2% 138
2020
Q3
Sell
-6,400
Closed -$2.32M 297
2020
Q2
$2.32M Buy
+6,400
New +$2.15M 0.08% 195

Other funds holding TMO

Capula Management's TMO Position: Q1 2026 in Review

Capula Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 188 shares worth $92.4K. The stake represents ﹤0.01% of the portfolio and ranks #911 among its holdings. This is a return to the name: Capula Management previously reported a position in TMO as recently as Q3 2025.

Capula Management first reported a position in TMO in Q1 2021 and has held it in 13 quarters since. The position peaked at $4.36M in Q2 2022. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Capula Management held 188 shares of Thermo Fisher Scientific worth $92.4K as of Q1 2026.
  • Thermo Fisher Scientific was a new Capula Management position in Q1 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #911 holding.
  • Capula Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 13 quarters since.
  • Capula Management's Thermo Fisher Scientific position peaked at $4.36M in Q2 2022.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.